Abstract

ABSTRACTIntroductionIn this study, we aimed to investigate the histological and clinical effect of angiotensin-converting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease.Materials and methodsLiver function tests, body mass index, waist circumference, lipid parameters, fasting blood glucose (FBG), hemoglobin A1c (HbA1c), homeostasis model assessment-IR (HOMA-IR), ACE, and ACE gene polymorphism were evaluated in the NAFLD group and control group. The study group was evaluated by dividing the group into four subgroups by ACE gene polymorphism (D/D homozygous, I/I homozygous, D/I heterozygous, I/D heterozygous). Liver biopsies were evaluated according to Brunt Classification.ResultsA total of 31 patients who were diagnosed with NAFLD and 40 healthy individuals were included in the study. The ACE level was found to be 11.69 ± 1.99 in the NAFLD group and 11.52 ± 1.72 in the control group (p = 0.70). There was a negative correlation between ACE levels and HOMA-IR levels (p = 0.008, r= −0.512). Biochemical parameters were not different among ACE gene polimorphism subgroups, except FBG (between D/D, I/D and D/I, I/D; p = 0.02). When the ACE levels were compared in terms of grade and stage, no significant difference was found (for stage and grade p = 0.68). The ACE gene polymorphism subgroups did not differ by histopathologic findings; grade and stage (for grade p = 0.42, for stage p = 0.92).ConclusionIn this study, we could not find a correlation of ACE and ACE gene polymorphism with metabolic risk factors and the disease severity in NAFLD.How to cite this articleTekatas DD, Bahcecioglu IH, Ispiroglu M, Sahin A, Ilhan N, Yalniz M, Demirel U. Role of Renin–Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease. Euroasian J Hepato-Gastroenterol 2016;6(2):137-142.

Highlights

  • In this study, we aimed to investigate the histological and clinical effect of angiotensinconverting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease

  • A total of 31 patients who were diagnosed with NAFLD and 40 healthy individuals were included in the study

  • In this study, we could not find a correlation of ACE and ACE gene polymorphism with metabolic risk factors and the disease severity in NAFLD

Read more

Summary

Introduction

We aimed to investigate the histological and clinical effect of angiotensinconverting enzyme (ACE) and ACE gene polymorphism in nonalcoholic fatty liver disease (NAFLD) and their roles in the progression of the disease. Nonalcoholic fatty liver disease (NAFLD) is a hepatic disease that may show a clinical course ranging from simple steatosis to fibrosis and hepatic cirrhosis.[1,2] Primarily, type 2 diabetes mellitus (DM), obesity, and hyperlipidemia and secondarily drugs, bypass surgery, pregnancy, lipid metabolism diseases, and total parenteral nutrition are involved in the etiology.[3,4] It is known that various hormones (leptin, resistin, adiponectin), neurotransmitters (noradrenalin, angiotensin [AT]-II, plasminogen activator inhibitor-1), and proinflammatory cytokines (tumor necrosis factor alpha and interleukin-6) are released from the adipose tissue and that they have fibrinogenic property.[5,6]. The effect of ACE gene polymorphism on fibrogenesis has been investigated in different liver diseases and different results have been obtained

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call